PARAMOUNT trial
PARAMOUNT Trial is a clinical trial that was conducted to evaluate the efficacy and safety of Pemetrexed as a maintenance therapy for patients with advanced Non-small cell lung cancer (NSCLC) who have not progressed after initial chemotherapy. The trial was a phase III, double-blind, placebo-controlled study.
Overview[edit | edit source]
The PARAMOUNT trial was designed to assess the benefits of maintenance therapy with Pemetrexed in patients with advanced NSCLC who had not progressed after four cycles of Pemetrexed-cisplatin induction therapy. The primary endpoint of the trial was progression-free survival, while secondary endpoints included overall survival, response rate, and safety.
Results[edit | edit source]
The results of the PARAMOUNT trial showed that maintenance therapy with Pemetrexed significantly improved progression-free survival in patients with advanced NSCLC. The trial also demonstrated a trend towards improved overall survival, although this was not statistically significant.
Implications[edit | edit source]
The findings of the PARAMOUNT trial have important implications for the management of patients with advanced NSCLC. They suggest that maintenance therapy with Pemetrexed may be a viable option for these patients, potentially improving their quality of life and survival outcomes.
See Also[edit | edit source]
References[edit | edit source]
PARAMOUNT trial Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD